000 01439 a2200433 4500
005 20250515145326.0
264 0 _c20090609
008 200906s 0 0 eng d
022 _a1476-5500
024 7 _a10.1038/cgt.2008.88
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLortal, B
245 0 0 _aPreclinical study of an ex vivo gene therapy protocol for hepatocarcinoma.
_h[electronic resource]
260 _bCancer gene therapy
_cApr 2009
300 _a329-37 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aCarcinoma, Hepatocellular
_xgenetics
650 0 4 _aCell Culture Techniques
650 0 4 _aDrug Evaluation, Preclinical
650 0 4 _aFibroblasts
_xmetabolism
650 0 4 _aGamma Rays
650 0 4 _aGenetic Therapy
_xmethods
650 0 4 _aGenetic Vectors
650 0 4 _aHumans
650 0 4 _aInterleukin-12 Subunit p35
_xbiosynthesis
650 0 4 _aInterleukin-12 Subunit p40
_xbiosynthesis
650 0 4 _aLiver Neoplasms
_xgenetics
650 0 4 _aRetroviridae
_xgenetics
650 0 4 _aTransduction, Genetic
700 1 _aGross, F
700 1 _aPeron, J M
700 1 _aPénary, M
700 1 _aBerg, D
700 1 _aHennebelle, I
700 1 _aFavre, G
700 1 _aCouderc, B
773 0 _tCancer gene therapy
_gvol. 16
_gno. 4
_gp. 329-37
856 4 0 _uhttps://doi.org/10.1038/cgt.2008.88
_zAvailable from publisher's website
999 _c18450376
_d18450376